Table V.
List of patents related to nanocarrier systems
| Description of invention | Patent number | Application | References |
|---|---|---|---|
| Preparation of nanoparticles containing paclitaxel formed from emulsion coated with human serum albumin by solvent evaporation method | US20046749868B1 | Targeting of drug delivery | [186] |
| PLGA gelatin nanoparticles containing paclitaxel covered with bioadhesive molecules | US2006034925A1 | Targeting of drug delivery | [187] |
| Liposomes prepared using sterically stabilized polysaccharide kelp containing curcumol and camptothecin | US2004192641 A1 | Drug delivery | [188] |
| Tween 80-coated doxorubicin polymeric nanoparticles | WO0074658 A1 | Drug delivery | [189] |
| Thomsen Friedenreich disaccharide antigen conjugated gold nanoparticles | US20070275007 A1 | Site-specific delivery | [190] |
| Fluoro deoxyuridine containing nanospheres developed by heating wax and dispersing drug into the melt | US2004234597A1 | Drug delivery | [191] |
| An aerosol system containing beclomethazone nanoparticles | US19985747001 | Drug delivery | [192] |
| Estradiol metabolites nanoparticle for pulmonary hypertension therapy | US20077192941 | Drug delivery | [193] |
| Self-assembled aggregated nanoparticle of amphipathic molecules civalenty linked to LM609 antibody and complexed to the plasmid | US2003013674A1 | Targeted gene therapy | [194] |
| MAGE-1 and Hsp70 based nano-vaccines/liposomes to form a fusion gene | CN1528452A | Vaccine therapy targeting | [195] |
| Formation of liposomes encapsulating Taxol® using high-pressure homogenization approach | US20006090955A | Drug delivery | [196] |
| Antibody–antigen delivery from fluorescein isothiocyante–dextran loaded carbon nanoparticle for imaging | US20006165440A | Targeting and radiotherapy imaging | [197] |
| Nanoparticles of Fe3O4 enclosed by dextran shell for covalent linkage with monoclonal antibody for Her-2 | WO03022360A2 | Thermotherapy and site-specific delivery | [198] |
| Delivery of anticancer drug to the solid tumors administering nanoparticles using ultrasonic radiation | US20006165506 | Cancer therapy and immunology | [199] |
| Folate molecules coated 5-fluorouracil nanocapsules formed by coacervation of bovine serum albumin followed by desolvation | EP1206251A1 | Targeting | [200] |
| Composite nanoparticles containing anticancer drug, a coating of hydrophilic layer of albumin, PEG, polyvinylpyrrolidine, poloxamer, polysaccharides, polysorbate, copolymers or combinations thereof. Nanoparticles were coated with a coating of a recognition element like antibody, a ligand, a carbohydrate or a nucleic acid and a ligand like folate, biotin, and tariquidar | WO/2017/156191 | To treat cancers of the anus, bile duct, bladder, bone, bone marrow, bowel, testis, cervix, head, neck, ovary, lung, etc. | [201] |
| Polymeric micellar-nanoparticle containing a graft copolymer containing polycationic polymer and PEG polymer. The graft copolymer and complexed nucleic acid condensed into a micellar shape were stable in biological media | US20160331845 A1 | Targeting of melanoma cancer cells, breast cancer cells, cervical cancer cells, and prostate cancer cells | [202] |
| Nanoemulsion containing a synergistic combination of antioxidants and cell a membrane stabilizer phospholipid | US 20150079176 A1 | Carriers of specific diarylchroman derivatives for treating breast cancer, colon cancer, uterine cancer, etc. | [203] |
| Suspensions and compositions of polymeric nanoparticles containing docetaxel | US20160151298A1 | Treating a solid tumor cancer | [204] |
| Antigen-capturing nanoparticles to capture tumor-released antigens | WO2017087692 A1 | Targeted therapy of blastoma, carcinoma, lymphoma, lung cancer, etc. | [205] |
PEG: polyethylene glycol